The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Trastuzumab versus MYL-1401O (a proposed trastuzumab biosimilar) in a phase I bioequivalence study: In vivo and in vitro immunomodulation.
 
R�©gine Audran
No Relationships to Disclose
 
Haithem Chtioui
Research Funding - Mylan (Inst)
 
Anne-Christine Thierry
No Relationships to Disclose
 
Carole Mayor
No Relationships to Disclose
 
Laure Vallotton
Research Funding - Mylan (Inst)
 
Kim Dao
Research Funding - Mylan (Inst)
 
Laura Rothuizen
Research Funding - Mylan (Inst)
 
Ali Maghraoui
No Relationships to Disclose
 
Eduardo J. Pennella
Employment - Mylan
Stock and Other Ownership Interests - Mylan
 
Françoise Brunner-Ferber
Stock and Other Ownership Interests - Advicenne; Johnson & Johnson; Novartis; Roche
Honoraria - Advicenne; C03; Theranexus
Consulting or Advisory Role - Advance Health Solutions; C03; Theranexus
 
Thierry Buclin
Research Funding - Mylan (Inst)
 
Francois Spertini
No Relationships to Disclose